Human papillomavirus vaccination coverage among 15-year-old girls in Mexico: a comparative analysis with the Region of the Americas based on World Health Organization indicators
DOI:
https://doi.org/10.71112/9qzep621Keywords:
Human papillomavirus, Vaccination, Vaccination coverage, Cervical cancer, Public health, Health Care CoverageAbstract
Introduction: Human papillomavirus (HPV) vaccination is the most effective strategy for preventing cervical cancer, a major cause of cancer-related morbidity and mortality among women worldwide. The World Health Organization (WHO) established a target of achieving 90% vaccination coverage among girls before 15 years of age.
Objective: To compare HPV vaccination coverage among 15-year-old girls in Mexico and the Region of the Americas between 2010 and 2024.
Methods: Descriptive and comparative ecological study based on secondary data obtained from the official WHO indicators platform.
Results: Differences in vaccination coverage and proximity to the international target are expected to be identified.
Conclusion: Continuous monitoring of vaccination coverage is essential to guide public health policies, strengthen national immunization programs, and accelerate the elimination of cervical cancer as a public health problem.
Downloads
References
Arbyn, M., Xu, L., Simoens, C., & Martin-Hirsch, P. P. L. (2018). Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database of Systematic Reviews, (5), CD009069.
Bosch, F. X., & de Sanjosé, S. (2007). The epidemiology of human papillomavirus infection and cervical cancer. Disease Markers, 23(4), 213–227.
Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., et al. (2020). Impact of HPV vaccination and cervical screening on cervical cancer elimination: A comparative modelling analysis. The Lancet, 395(10224), 575–590.
Bruni, L., Saura-Lázaro, A., Montoliu, A., Brotons, M., Alemany, L., Diallo, M. S., et al. (2021). HPV vaccination introduction worldwide and WHO strategy: Advances and remaining challenges. The Lancet Global Health, 9(2), e125–e127.
Canfell, K., Kim, J. J., Brisson, M., et al. (2020). Mortality impact of achieving WHO cervical cancer elimination targets: A comparative modelling analysis. The Lancet.
Causey, K., Fullman, N., Sorensen, R. J. D., et al. (2021). Estimating global disruptions to routine childhood immunisation during the COVID-19 pandemic. The Lancet, 398(10299), 522–534.
Centro Nacional para la Salud de la Infancia y la Adolescencia. (s. f.). Programa de Vacunación Universal. Secretaría de Salud de México.
Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013). Human papillomavirus and cervical cancer. The Lancet, 382(9895), 889–899.
de Martel, C., Plummer, M., Vignat, J., & Franceschi, S. (2017). Worldwide burden of cancer attributable to HPV by site, country and HPV type. International Journal of Cancer, 141(4), 664–670.
Drolet, M., Bénard, É., Pérez, N., Brisson, M., & HPV Vaccination Impact Study Group. (2019). Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: Updated systematic review and meta-analysis. The Lancet, 394(10197), 497–509.
Falcaro, M., Castañon, A., Ndlela, B., et al. (2021). The effects of the national HPV vaccination programme in England. The Lancet, 398(10316), 2084–2092.
Franceschi, S., & Wild, C. P. (2013). Meeting the global demands of epidemiologic transition. International Journal of Cancer, 133(9), 1977–1981.
Garland, S. M., Kjaer, S. K., Muñoz, N., et al. (2016). Impact and effectiveness of HPV vaccination programmes: A comprehensive review. Vaccine, 34(52), 6351–6360.
International Agency for Research on Cancer. (2024). Cancer Today (GLOBOCAN). International Agency for Research on Cancer.
Jit, M., Brisson, M., Laprise, J. F., et al. (2020). Impact of HPV vaccination worldwide: Modelling analysis. The Lancet Global Health.
Markowitz, L. E., Gee, J., Chesson, H., & Stokley, S. (2018). Ten years of human papillomavirus vaccination in the United States. Academic Pediatrics, 18(2 Suppl.), S3–S10.
Pan American Health Organization. (2022). HPV vaccine introduction in the Americas: A decade of progress and lessons learned. Expert Review of Vaccines.
Pan American Health Organization. (2024). Immunization in the Americas: 2024 Summary. Pan American Health Organization.
Pan American Health Organization. (s. f.). Comprehensive cervical cancer prevention and control. Pan American Health Organization.
Rachlin, A., Danovaro-Holliday, M. C., Murphy, P., Sodha, S. V., & Wallace, A. S. (2022). Routine vaccination coverage worldwide, 2021. MMWR Morbidity and Mortality Weekly Report, 71(44), 1396–1400.
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007). Human papillomavirus and cervical cancer. The Lancet, 370(9590), 890–907.
Secretaría de Salud. (s. f.). Programa de Acción Específico: Vacunación Universal. Gobierno de México.
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249.
UNICEF. (2020). Youth literacy rate (15–24 years), Mexico. UNICEF Data.
World Health Organization. (2020). Global strategy to accelerate the elimination of cervical cancer as a public health problem. World Health Organization.
World Health Organization. (2021). WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention (2nd ed.). World Health Organization.
World Health Organization. (2024a). HPV vaccination. World Health Organization.
World Health Organization. (2024b). Immunizing against HPV. World Health Organization.
World Health Organization. (2024). Global Health Observatory. World Health Organization.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Nicoli Viana Alves (Autor/a)
This work is licensed under a Creative Commons Attribution 4.0 International License.
